Page 22 - Read Online

Ruff et al. Hepatoma Res 2023;9:17 https://dx.doi.org/10.20517/2394-5079.2023.18 Page 11 of 12

2018;105:839-47. DOI
26. Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced
biliary tract cancer: a retrospective single-center study. Ann Surg Oncol 2013;20:318-24. DOI
27. Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an
overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin 2023;73:198-222. DOI PubMed
28. D'Angelica M, Fong Y, Weber S, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases.
Ann Surg Oncol 2003;10:183-9. DOI
29. Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful
diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 2006;20:721-5. DOI
30. Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM. Intrahepatic cholangiocarcinoma: expert consensus
statement. HPB 2015;17:669-80. DOI PubMed PMC
31. Shindoh J, Tzeng CW, Aloia TA, et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for
colorectal liver metastases. Ann Surg Oncol 2013;20:2493-500. DOI PubMed PMC
32. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for
colorectal liver metastases. Br J Surg 2007;94:274-86. DOI PubMed
33. Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with
and without preoperative portal vein embolization. Arch Surg 2002;137:675-80; discussion 680. DOI PubMed
34. Abdalla EK. Resection of colorectal liver metastases. J Gastrointest Surg 2011;15:416-9. DOI PubMed
35. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection:
methodology and clinical associations. Surgery 2000;127:512-9. DOI
36. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in
resectional surgery for hepatic tumors. Hepatology 1997;26:1176-81. DOI
37. Thirunavukarasu P, Aloia TA. Preoperative assessment and optimization of the future liver remnant. Surg Clin North Am 2016;96:197-
205. DOI PubMed
38. Rassam F, Olthof PB, van Lienden KP, et al. Comparison of functional and volumetric increase of the future remnant liver and
postoperative outcomes after portal vein embolization and complete or partial associating liver partition and portal vein ligation for
staged hepatectomy (ALPPS). Ann Transl Med 2020;8:436. DOI PubMed PMC
39. Li M, Wang J, Song J, et al. Preoperative ICG test to predict posthepatectomy liver failure and postoperative outcomes in hilar
cholangiocarcinoma. Biomed Res Int 2021;2021:8298737. DOI PubMed PMC
40. Owen ML, Beal EW. Minimally invasive surgery for intrahepatic cholangiocarcinoma: patient selection and special considerations.
Hepat Med 2021;13:137-43. DOI PubMed PMC
41. Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection
for intrahepatic cholangiocarcinoma. Surg Endosc 2016;30:4835-40. DOI
42. Wei F, Lu C, Cai L, Yu H, Liang X, Cai X. Can laparoscopic liver resection provide a favorable option for patients with large or
multiple intrahepatic cholangiocarcinomas? Surg Endosc 2017;31:3646-55. DOI PubMed
43. Uy BJ, Han HS, Yoon YS, Cho JY. Laparoscopic liver resection for intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech
A 2015;25:272-7. DOI PubMed
44. Ratti F, Cipriani F, Ariotti R, et al. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for
intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc 2016;30:1999-
2010. DOI
45. Neoptolemos JP, Moore MJ, Cox TF, et al; European Study Group for Pancreatic Cancer. Effect of adjuvant chemotherapy with
fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the
ESPAC-3 periampullary cancer randomized trial. JAMA 2012;308:147-56. DOI
46. Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic
cholangiocarcinoma. Ann Surg Oncol 2015;22:4020-8. DOI
47. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of
prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140-5. DOI
48. Endo Y, Sasaki K, Moazzam Z, et al. Higher tumor burden status dictates the impact of surgical margin status on overall survival in
patients undergoing resection of intrahepatic cholangiocarcinoma. Ann Surg Oncol 2023;30:2023-32. DOI
49. NCCN guidelines version: hepatobiliary cancers. Available from: https://www.nccn.org/guidelines/guidelines-
detail?category=1&id=1438 [Last accessed on 12 May 2023].
50. Cloyd JM, Ejaz A, Pawlik TM. The landmark series: intrahepatic cholangiocarcinoma. Ann Surg Oncol 2020;27:2859-65. DOI
PubMed
51. Zhang XF, Chen Q, Kimbrough CW, et al. Lymphadenectomy for intrahepatic cholangiocarcinoma: has nodal evaluation been
increasingly adopted by surgeons over time? a national database analysis. J Gastrointest Surg 2018;22:668-75. DOI
52. Zhang XF, Xue F, Dong DH, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic
cholangiocarcinoma impact prognosis. Ann Surg 2021;274:e1187-95. DOI
53. Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic
cholangiocarcinoma: a multi-institutional analysis. J Surg Oncol 2017;116:133-9. DOI